These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6490167)

  • 21. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients.
    Marcellin P; Ouzan D; Degos F; Brechot C; Metman EH; Degott C; Chevalier M; Berthelot P; Trepo C; Benhamou JP
    Hepatology; 1989 Sep; 10(3):328-31. PubMed ID: 2474480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-associated receptors for polymerized human serum albumin (RpHSA) in patients with chronic active hepatitis B treated with recombinant leukocyte A interferon.
    Gerken G; Manns M; Hess G; Meyer zum Büschenfelde KH
    Digestion; 1987; 37(2):96-102. PubMed ID: 3040500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of human leukocyte interferon on chronic active hepatitis B in children.
    Hashida T; Sawada T; Esumi N; Kinugasa A; Kusunoki T; Kishida T
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):20-5. PubMed ID: 3981364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
    Ascione A; Amitrano L; Riccio E; De Lella A; Canestrini C; de Bellis G; D'Alessandro R; Fiore R; Padulano P
    Hepatogastroenterology; 1984 Jun; 31(3):123-4. PubMed ID: 6469200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
    Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
    Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
    JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of acyclovir in stable chronic HBsAg, HBeAg-positive carriers.
    Alexander GJ; Fagan EA; Hegarty JE; Rolando N; Guarner P; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S123-7. PubMed ID: 3298404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vidarabine treatment of chronic active hepatitis associated with hepatitis B virus multiplication. A randomized multicenter study].
    Ouzan D; Degos F; Marcellin P; Linberg J; Chevallier M; Degott C; Bréchot C; Chossegros P; Weiss AM; Hirtz J
    Gastroenterol Clin Biol; 1987; 11(8-9):568-73. PubMed ID: 3308617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
    Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B].
    Le Quellec A; Bories P; Bauret P; Piera S; Ouzan D; Trepo C; Michel H
    Gastroenterol Clin Biol; 1986 Oct; 10(10):687-8. PubMed ID: 2878855
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate.
    Hoofnagle JH; Davis GL; Hanson RG; Pappas SC; Peters MG; Avigan MI; Waggoner JG; Howard R; Jones EA; Straus SE
    J Med Virol; 1985 Feb; 15(2):121-8. PubMed ID: 2579192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
    Fiume L; Cerenzia MR; Bonino F; Busi C; Mattioli A; Brunetto MR; Chiaberge E; Verme G
    Lancet; 1988 Jul; 2(8601):13-5. PubMed ID: 2455204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy.
    Marcellin P; Martinot-Peignoux M; Loriot MA; Giostra E; Boyer N; Thiers V; Benhamou JP
    Ann Intern Med; 1990 Feb; 112(3):227-8. PubMed ID: 2297196
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.
    Hafkin B; Pollard RB; Tiku ML; Robinson WS; Merigan TC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):781-7. PubMed ID: 533259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study of steroid withdrawal followed by oral acyclovir in the treatment of chronic type B hepatitis.
    Minuk GY; German GB; Bernstein C; Benarroch A; Gauthier T; Sekla L
    Clin Invest Med; 1992 Dec; 15(6):506-12. PubMed ID: 1286532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic effect of combined treatment with Ara-A dauricine and Chinese herbs in chronic hepatitis B infection].
    Fu XX
    Zhonghua Nei Ke Za Zhi; 1991 Aug; 30(8):498-501, 522. PubMed ID: 1794248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication.
    Perrillo RP
    J Hepatol; 1986; 3 Suppl 2():S57-64. PubMed ID: 2439577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.